Abstract: A manufacturing method for providing a corrosion prevention layer on a cylindrical secondary battery including a jelly-roll type electrode assembly having a structure in which a first electrode, a second electrode, and a separator interposed therebetween are wound in one direction based on a winding axis, a battery can accommodating the electrode assembly and the battery can including a metal plated layer, and a connection lead plate joining the battery can and the electrode assembly, of which the method includes applying a resin to a portion where the metal plated layer is welded to the connection lead plate, and forming the corrosion prevention layer by curing the resin by ultraviolet rays. The resin includes one or more liquid materials. The one or more liquid materials are ultraviolet curable. The one or more liquid materials have a viscosity of 1 cP to 5000 cP.

Abstract: An angle measurement system using a magnet and provided with first and second tracks includes an absolute angle calculation unit configured to calculate an absolute angle of a position of the magnet by using a 1-1th digital signal obtained by measuring a magnetic field signal of the first track and converted into a digital signal, a 1-2th digital signal obtained by measuring the magnetic field signal of the first track and converted into a digital signal, a 2-1th digital signal obtained by measuring a magnetic field signal of the second track and converted into a digital signal, and a 2-2th digital signal obtained by measuring the magnetic field signal of the second track and converted into a digital signal.

Abstract: The present invention relates to a composition for proliferating natural killer cells, comprising feeder cells and a method for proliferating natural killer cells. Specifically, the present invention relates to a method for proliferating natural killer cells by using feeder cells that are transformed to express at least one gene selected from the group consisting of B7H6, CD137L, IL-15, and IL-15R?.

Abstract: Disclosed is an anticancer composition, comprising an inhibitor against WIG1 and/or YPEL5 or against a protein encoded by the gene. A composition for screening an anticancer agent comprising a nucleic acid having a sequence complementary to an mRNA of WIG1 and/or YPEL5, or an antibody to a protein encoded by the gene is also provided. Also, a method is provided for screening an anticancer agent, which comprises: (A) quantitatively analyzing expression of WIG1 and/or YPEL5 at an mRNA or protein level in a tumor cell which is not treated with a candidate for an anticancer agent; (B) quantitatively analyzing expression of the gene at an mRNA or protein level in a tumor cell after treatment of the candidate for an anticancer agent; and (C) selecting the candidate if the expression level of the gene is increased in step (B), compared to step (A).

Abstract: Disclosed is an anticancer composition, comprising an inhibitor against WIG1 and/or YPEL5 or against a protein encoded by the gene. A composition for screening an anticancer agent comprising a nucleic acid having a sequence complementary to an mRNA of WIG1 and/or YPEL5, or an antibody to a protein encoded by the gene is also provided. Also, a method is provided for screening an anticancer agent, which comprises: (A) quantitatively analyzing expression of WIG1 and/or YPEL5 at an mRNA or protein level in a tumor cell which is not treated with a candidate for an anticancer agent; (B) quantitatively analyzing expression of the gene at an mRNA or protein level in a tumor cell after treatment of the candidate for an anticancer agent; and (C) selecting the candidate if the expression level of the gene is increased in step (B), compared to step (A).